Cargando…
Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is characterized by symmetrical polyarthritis and limb pitting edema. Although the detailed mechanisms of this syndrome have not been clearly understood, some agents including dipeptidyl peptidase-4 inhibitors have been...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876704/ https://www.ncbi.nlm.nih.gov/pubmed/35208612 http://dx.doi.org/10.3390/medicina58020289 |
_version_ | 1784658236666806272 |
---|---|
author | Sawamura, Toshitaka Karashima, Shigehiro Ohmori, Ai Sawada, Kei Kometani, Mitsuhiro Takeda, Yoshiyu Yoneda, Takashi |
author_facet | Sawamura, Toshitaka Karashima, Shigehiro Ohmori, Ai Sawada, Kei Kometani, Mitsuhiro Takeda, Yoshiyu Yoneda, Takashi |
author_sort | Sawamura, Toshitaka |
collection | PubMed |
description | Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is characterized by symmetrical polyarthritis and limb pitting edema. Although the detailed mechanisms of this syndrome have not been clearly understood, some agents including dipeptidyl peptidase-4 inhibitors have been reported to induce RS3PE syndrome. However, glucagon-like peptide-1 (GLP-1) analogues have not been reported to be associated with this syndrome. A 91-year-old woman was admitted to our hospital with complaints of severe polyarthritis and limb edema. She was diagnosed with RS3PE syndrome. Oral prednisolone improved her symptoms. However, her symptoms worsened after the administration of dulaglutide, with elevated serum inflammatory markers. Discontinuation of dulaglutide without additional treatment improved her symptoms and laboratory findings. This case might indicate the possibility of development and worsening of RS3PE syndrome caused after GLP-1 analogue. |
format | Online Article Text |
id | pubmed-8876704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88767042022-02-26 Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide Sawamura, Toshitaka Karashima, Shigehiro Ohmori, Ai Sawada, Kei Kometani, Mitsuhiro Takeda, Yoshiyu Yoneda, Takashi Medicina (Kaunas) Case Report Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is characterized by symmetrical polyarthritis and limb pitting edema. Although the detailed mechanisms of this syndrome have not been clearly understood, some agents including dipeptidyl peptidase-4 inhibitors have been reported to induce RS3PE syndrome. However, glucagon-like peptide-1 (GLP-1) analogues have not been reported to be associated with this syndrome. A 91-year-old woman was admitted to our hospital with complaints of severe polyarthritis and limb edema. She was diagnosed with RS3PE syndrome. Oral prednisolone improved her symptoms. However, her symptoms worsened after the administration of dulaglutide, with elevated serum inflammatory markers. Discontinuation of dulaglutide without additional treatment improved her symptoms and laboratory findings. This case might indicate the possibility of development and worsening of RS3PE syndrome caused after GLP-1 analogue. MDPI 2022-02-14 /pmc/articles/PMC8876704/ /pubmed/35208612 http://dx.doi.org/10.3390/medicina58020289 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Sawamura, Toshitaka Karashima, Shigehiro Ohmori, Ai Sawada, Kei Kometani, Mitsuhiro Takeda, Yoshiyu Yoneda, Takashi Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide |
title | Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide |
title_full | Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide |
title_fullStr | Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide |
title_full_unstemmed | Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide |
title_short | Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide |
title_sort | remitting seronegative symmetrical synovitis with pitting edema syndrome worsen after the administration of dulaglutide |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876704/ https://www.ncbi.nlm.nih.gov/pubmed/35208612 http://dx.doi.org/10.3390/medicina58020289 |
work_keys_str_mv | AT sawamuratoshitaka remittingseronegativesymmetricalsynovitiswithpittingedemasyndromeworsenaftertheadministrationofdulaglutide AT karashimashigehiro remittingseronegativesymmetricalsynovitiswithpittingedemasyndromeworsenaftertheadministrationofdulaglutide AT ohmoriai remittingseronegativesymmetricalsynovitiswithpittingedemasyndromeworsenaftertheadministrationofdulaglutide AT sawadakei remittingseronegativesymmetricalsynovitiswithpittingedemasyndromeworsenaftertheadministrationofdulaglutide AT kometanimitsuhiro remittingseronegativesymmetricalsynovitiswithpittingedemasyndromeworsenaftertheadministrationofdulaglutide AT takedayoshiyu remittingseronegativesymmetricalsynovitiswithpittingedemasyndromeworsenaftertheadministrationofdulaglutide AT yonedatakashi remittingseronegativesymmetricalsynovitiswithpittingedemasyndromeworsenaftertheadministrationofdulaglutide |